Organization
Ironwood Pharmaceuticals
3 clinical trials
Clinical trial
A Phase 1 Placebo-controlled Study of the Safety and Tolerability of Rectally Administered, Multiple-ascending Doses of IW-3300 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
A Phase 1 Placebo-controlled Study of the Safety and Tolerability of Rectally Administered Single Ascending Doses of IW-3300 in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-03-09
Clinical trial
A Phase 2 Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate the Efficacy, Safety, and Tolerability of 2 Dose Levels of IW-3300 Administered Rectally for 12 Weeks to Treat Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromeStatus: Recruiting, Estimated PCD: 2025-10-01